(Q34247041)

English

Comparing fluorescence in situ hybridization and chromogenic in situ hybridization methods to determine the HER2/neu status in primary breast carcinoma using tissue microarray.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:13679458%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

Comparing fluorescence in situ hybridization and chromogenic in situ hybridization methods to determine the HER2/neu status in primary breast carcinoma using tissue microarray (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:13679458%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

breast carcinoma

1 reference

based on heuristic

inferred from title

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:13679458%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

author name string

Kyeongmee Park

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:13679458%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

Jungyeon Kim

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:13679458%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

Sungjig Lim

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:13679458%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

Jung Young Lee

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:13679458%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

publication date

1 September 2003

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:13679458%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

Modern Pathology

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:13679458%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

16

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:13679458%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:13679458%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

937-943

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:13679458%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

describes a project that uses

Tissue microarray

1 reference

based on heuristic

inferred from title

https://scigraph.springernature.com/pub.10.1097/01.mp.0000086487.78558.7d

0 references

p185, a product of the neu proto-oncogene, is a receptorlike protein associated with tyrosine kinase activity

1 reference

https://api.crossref.org/works/10.1097%2F01.MP.0000086487.78558.7D

21 January 2018

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

1 reference

https://api.crossref.org/works/10.1097%2F01.MP.0000086487.78558.7D

21 January 2018

ERBB2 amplification in breast cancer analyzed by fluorescence in situ hybridization

1 reference

https://api.crossref.org/works/10.1097%2F01.MP.0000086487.78558.7D

21 January 2018

Chromogenic in situ hybridization: a practical alternative for fluorescence in situ hybridization to detect HER-2/neu oncogene amplification in archival breast cancer samples

1 reference

https://api.crossref.org/works/10.1097%2F01.MP.0000086487.78558.7D

21 January 2018

Use of a cDNA microarray to analyse gene expression patterns in human cancer

1 reference

https://api.crossref.org/works/10.1097%2F01.MP.0000086487.78558.7D

21 January 2018

Tissue microarrays for high-throughput molecular profiling of tumor specimens

1 reference

https://api.crossref.org/works/10.1097%2F01.MP.0000086487.78558.7D

21 January 2018

Tissue microarray technology for high-throughput molecular profiling of cancer

1 reference

https://api.crossref.org/works/10.1097%2F01.MP.0000086487.78558.7D

21 January 2018

Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up

1 reference

https://api.crossref.org/works/10.1097%2F01.MP.0000086487.78558.7D

21 January 2018

Validation of tissue microarray technology in breast carcinoma

1 reference

https://api.crossref.org/works/10.1097%2F01.MP.0000086487.78558.7D

21 January 2018

erbB-2 and response to doxorubicin in patients with axillary lymph node-positive, hormone receptor-negative breast cancer

1 reference

https://api.crossref.org/works/10.1097%2F01.MP.0000086487.78558.7D

21 January 2018

c-erbB-2 expression and response to adjuvant therapy in women with node-positive early breast cancer

1 reference

https://api.crossref.org/works/10.1097%2F01.MP.0000086487.78558.7D

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34247041&oldid=1880558986"